Literature DB >> 955696

Effect of Mycoplasma pheumoniae infection on cell-mediated immunity.

G Biberfeld, G Sterner.   

Abstract

The effect of Mycoplasma pneumoniae infection on cell-mediated immunity was examined by two methods: the first method was the tuberculin skin test and the other was the measurement of the in vitro lymphocyte stimulation response to purified protein derivative (PPD) of tuberculin. Twenty-nine patients out of a total of 47 patients with a lower respiratory tract illness caused by M. pneumoniae had a negative tuberculin skin test when first tested. Twenty-three out of 26 patients with a negative tuberculin reaction in the early phase of the illness had a positive skin test when they were retested several weeks or months after the illness. The lymphocyte stimulation response to PPD was examined in 13 patients. In eight of these cases the lymphocyte response to PPD was significantly lower during illness than after recovery. Six control subjects showed no significant difference in their lymphocyte responsiveness to PPD when examined on two different occasions. These studies show that M.pneumoniae infection causes transient depression of cell-mediated immunity.

Entities:  

Mesh:

Year:  1976        PMID: 955696     DOI: 10.1007/BF01638416

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  In vitro response of human lymphocytes to Mycoplasma pneumoniae.

Authors:  G W Fernald
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

2.  Depression of cell-mediated immunity during acute infectious mononucleosis.

Authors:  R J Mangi; J C Niederman; J E Kelleher; J M Dwyer; A S Evans; F S Kantor
Journal:  N Engl J Med       Date:  1974-11-28       Impact factor: 91.245

3.  Delayed hypersensitivity in mycoplasma pneumoniae infections.

Authors:  H Mizutani; T Kitayama; A Hayakawa; E Nagayama
Journal:  Lancet       Date:  1971-01-23       Impact factor: 79.321

4.  Cell-mediated immune response following Mycoplasma pneumoniae infection in man. II. Leucocyte migration inhibition.

Authors:  G Biberfeld
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

5.  Cell-mediated immune response following Mycoplasma pneumoniae infection in man. I. Lymphocyte stimulation.

Authors:  G Biberfeld; P Biberfeld; G Sterner
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

Review 6.  Infection, anergy and cell-mediated immunity.

Authors:  F S Kantor
Journal:  N Engl J Med       Date:  1975-03-20       Impact factor: 91.245

7.  Tuberculin anergy in patients with Mycoplasma pneumoniae infection.

Authors:  G Biberfeld; G Sterner
Journal:  Scand J Infect Dis       Date:  1976
  7 in total
  6 in total

1.  Post-infectious encephalomyelitis associated with Mycoplasma pneumoniae and Legionella pneumophila infection.

Authors:  P J Easterbrook; E G Smyth
Journal:  Postgrad Med J       Date:  1992-02       Impact factor: 2.401

2.  Postinfectious meningoencephalitis complicating Mycoplasma pneumoniae in a child.

Authors:  J C den Heijer; A C Peters; G W van Gemert
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-05       Impact factor: 10.154

3.  Aortic valve endocarditis associated with Legionella infection after Mycoplasma pneumonia.

Authors:  P Littrup; J K Madsen; K Lind
Journal:  Br Heart J       Date:  1987-09

Review 4.  Fulminant Mycoplasma pneumoniae pneumonia.

Authors:  E D Chan; C H Welsh
Journal:  West J Med       Date:  1995-02

Review 5.  Manifestations and complications of Mycoplasma pneumoniae disease: a review.

Authors:  K Lind
Journal:  Yale J Biol Med       Date:  1983 Sep-Dec

Review 6.  Immunologic mechanisms suggested in the association of M. pneumoniae infection and extrapulmonary disease: a review.

Authors:  G W Fernald
Journal:  Yale J Biol Med       Date:  1983 Sep-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.